Navigation Links
Phase II Ibrutinib Monotherapy Study Shows CLL Patients Achieved Rapid and Sustainable Disease Control Irrespective of Age or High Risk Prognostic Factor
Date:4/8/2013

esigns, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medical healthcare needs; and to identify promising product candidates based on scientific development and administrational expertise, develop our products in a rapid, cost-efficient manner and pursue commercialization and/or development partners when and where appropriate.

Presently, Pharmacyclics has three product candidates in clinical development and several preclinical molecules in lead optimization. The Company is committed to high standards of ethics, scientific rigor, and operational efficiency as it moves each of these programs to viable commercialization.

The Company is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us at http://www.pharmacyclics.com.

NOTE: This announcement may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements, among others, relating to our future capital requirements and the sufficiency of our current assets to meet these requirements, our future results of operations, our expectations for and timing of ongoing or future clinical trials and regulatory approvals for any of our product candidates, and our plans, objectives, expectations and intentions. Because these statements apply to future events, they are subject to risks and uncertainties. When used in this announcement, the words "anticipate", "believe", "estimate", "expect", "expectation", "should", "would", "project", "plan", "predict", "intend" and similar expressions are intended to identify such forward-looking statements. These forward-looking st
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
2. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
3. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
6. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
7. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
8. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
9. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
10. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
11. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Mass. , Aug. 21, 2014  Decision ... COPD,  physicians in Brazil ... follow clinical guidelines and commonly prescribe long-acting beta-agonist ... although they do so within current severe cost/coverage ... (FDCs) that are expected to launch in these ...
(Date:8/21/2014)... , N.Y. and HAMBURG, Germany , ... announced it is collaborating with Deutsches Elektronen-Synchrotron ( DESY ... Germany , to speed up management and storage ... Big Data and Analytics architecture based on IBM ... per second of data at peak performance and help ...
(Date:8/21/2014)... Aug. 21, 2014  Seventy-one percent of Americans believe the ... a serious public health and safety issue in ... survey released today by Repass & Partners, a ... "Americans understand the severity of the prescription medication abuse problem ... this very serious health situation facing our country," Rex ...
Breaking Medicine Technology:Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... 2011 Columbia Laboratories, Inc. (Nasdaq: CBRX ) ... announced that the U.S. Food and Drug Administration (FDA) has ... ® (progesterone gel) for the reduction of risk of ... the mid-trimester of pregnancy. The acceptance of the NDA for ...
... (NASDAQ: OMER ) today reported that it has ... P2Y8 and OPN4. P2Y8 (also known as P2RY8) is associated ... white blood cells. ALL is the most common type of ... regulation of circadian rhythms, and could provide a target for ...
Cached Medicine Technology:Columbia Laboratories' NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA 2Columbia Laboratories' NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA 3Columbia Laboratories' NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA 4Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders 2Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders 3Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders 4
(Date:8/21/2014)... CA (PRWEB) August 21, 2014 The costs for ... past two decades, according to new insurance industry studies. The Quotes ... insurance finder to locate affordable plans from all 50 states at ... pays more than $50 for a routine visit or complex surgery ... coverage. Every user of the system will be asked to provide ...
(Date:8/21/2014)... Heights, MI (PRWEB) August 21, 2014 ... emails informing a taxpayer that their federal tax payment ... email domain appears to come from the IRS, “tax@irs.gov”, ... victims to provide personal and financial information. , While ... years now, an uptick in phishing activity is occurring ...
(Date:8/21/2014)... exercise is a challenge. Thankfully, there are Zombies chasing you. ... more than 31,000 health and fitness apps on the market ... use games to increase physical activity. , Gamification is currently ... cash in to help people get fit. Whether or not ... , "It,s just been assumed that gamified apps will work, ...
(Date:8/21/2014)... Texas MD Anderson Cancer Center today announced a new ... screening at a network of community breast care centers ... November, MD Anderson will become the exclusive provider of ... 10 breast care centers, located in Memorial City, The ... the network will expand to Memorial Hermann,s locations in ...
(Date:8/21/2014)... Aug. 21, 2014 (HealthDay News) -- Black mothers are ... and here,s one possible reason why: Hospitals in neighborhoods ... than those in areas with more white residents, a ... breast-feeding are much less common in medical centers where ... the U.S. Centers for Disease Control and Prevention reported ...
Breaking Medicine News(10 mins):Health News:Pet Insurance Finder for 50 States Launched at Insurance Website Online 2Health News:Beware Of Phony “Tax Payment Rejected” IRS Emails 2Health News:Playing hunger games: Are gamified health apps putting odds in your favor? 2Health News:MD Anderson and Memorial Hermann to operate breast screening network across Houston area 2Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2
... the nation,s leader in pain prescription monitoring, announced ... with Aetna to offer Aetna,s network of providers ... monitoring process. Ameritox,s patented Rx Guardian(SM) methodology is ... a patented methodology to help physicians assess whether ...
... The Ohio State University , Cardinal Health and ... a collaboration that will invest more than $10 million ... industry, combining Ohio State,s Wright Center of Innovation in ... commercialization expertise for molecular imaging agents.Molecular imaging is one ...
... LINE OF NATURAL, NON-TOXIC AND EFFECTIVE HOUSEHOLD CLEANERS OFFER ... FAMILIES CLEAN AND SAFENEW YORK, April 29 ... Kevin Schwartz and Keith Garber of KAS Direct, founders ... cleaning solutions for households with infants and growing families ...
... Security Intelligence, and Risk Management Tools Now All in One ... ... swine flu, political instability, kidnapping and piracy dominating global headlines, MEDEX ... intelligence across medical, security, travel and risk management disciplines. By ...
... released today by the Center to Expose and Close Animal ... Close Animal Factories (CECAF) will hold a media teleconference to ... "factories." Among the topics will be Smithfield Foods at ... Officials in Mexico are looking at "manure lagoons" and ...
... Action to Protect Public,s Oral HealthCHICAGO, April 29 ... exclusively for the general dentist, reminds legislators that dentistry is ... must be taken into consideration in any effort by Congress ... critical issue for general dentistry is access to care. The ...
Cached Medicine News:Health News:Ameritox(R) Contracts With Aetna for Prescription Drug Monitoring Services 2Health News:The Ohio State University, Cardinal Health, State of Ohio to Invest $10 Million to Advance Medical Imaging Industry 2Health News:Preventative Safety Tips Timed to Swine Flu Outbreak 2Health News:MEDEX Announces New, Enhanced and Customizable Member Center 2Health News:MEDEX Announces New, Enhanced and Customizable Member Center 3Health News:MEDEX Announces New, Enhanced and Customizable Member Center 4Health News:Academy of General Dentistry Access to Care White Paper 2
... Knee System is a long term, quality ... Available in both posterior stabilized and anatomically ... System provides the flexibility needed to address ... ease of identification keeps the user in ...
... Virtual Fluoroscopy software from ... has incorporated ease of ... features such as multiplanar ... models of image guided ...
... T.L.I.F. SG Instruments are the next evolution ... comprehensive and functionally sound instruments.. The T.L.I.F. ... disc removal and disc preparation instruments designed ... Excellent design, a wide range of instrument ...
... is a family of multislice CT scanners. ... Mx8000 also is available in an affordable ... same friendly user interface, advanced applications and ... Dual and Quad systems can be upgraded ...
Medicine Products: